PharmaLex’s Post

How can pharma companies successfully embed integrated and open innovation? In this white paper, we explore the ways that companies can successfully apply both an integrated and open innovation approach to their R&D and commercial activities, with an emphasis on: - Open innovation approaches that reach beyond traditional one-to-one partnering and licensing - Important challenges of effective integrated and open innovation: finding quality, embracing the outside, and managing the integration of the outside and inside - Ways to overcome these challenges to effectively embrace innovation Click here to download: https://lnkd.in/eyMDM8KG #Innovation #ExternalInnovation #RandD #Commercial #MidPharmas #Pharma #Strategy #Consulting

[Blog] #DYK that digital transformation is the top focus for innovation across #pharma, #medtech, and #hightech? In this blog by Hemant Makhija, learn more about challenges affecting innovation across these industries and priorities to consider in 2024: https://lnkd.in/ePH6n95g #ModelN #RevenueOptimization #RevenueManagement

In 2023, the #pharmaceutical industry revived its focus on significant dealmaking in response to the upcoming loss of patent protection for key products. For #lifesciences companies, the time is now to engage in strategic deals that ensure future value. With global business and regulatory landscapes shifting, companies must focus on fostering robust partnerships, flexible deal structures, and adaptive strategies. Check out more insights in our 2024 EY Firepower Report: https://lnkd.in/edeGYCBW #MnA #BigPharma 

Cutting through the noise in the crowded CDMO space means focusing on your customers' key needs. Biotech startups are often constrained by budget and time as they race against their burn rate, and may also lack regulatory expertise. Pharma companies, on the other hand, typically value flexibility and efficiencies of scale. By positioning your services around the right balance of cost-effectiveness, time to market, and regulatory de-risking, your CDMO can outshine competitors offering generic capabilities. What customer pain points are your marketing efforts addressing? Take a look at our latest Marketing Tips article to see where you should be focusing your messaging: https://hubs.li/Q02F6B5k0 #BiotechMarketing #LifeScienceMarketing #CDMO #Pharma #TacticalMarketing

Join us at the 6th Annual Pharma Manufacturing and Automation Convention, Powered by Eminence Business Media - A Eminence Group Company. Our panel of industry veterans will delve into cutting-edge tech applications revolutionizing pharma production. Don't miss this opportunity to stay ahead of the curve! Stay tuned to Archimedis Digital for more updates Anand Govindarajan |Rangarajan Rajamani|Aashish Bharadwaj R|  #digitaltransformation #partnership #pharma #pharmamanufacturing #pharmaIT #PharmaInnovation #EminenceGroup #ManufacturingTech #ArchimedisDigital #PharmaAutomation #TechInnovation

A new change of pace is forcing #pharma companies to reconsider their offerings, and as a result, traditional models will fall behind. In the latest article in our series, Paula Bellostas Muguerza, Florian Leschinsky, and Keena Patel-Moran explore the question: How can pharma companies rethink their value propositions and resync their engagement models?: https://bit.ly/4598RWs

Pharma companies that embrace centralized tech – with a global infrastructure supporting local teams – will be able to gain speed, efficiency and scale advantages over rivals that remain trapped in decentralized silos. Read this blog to discover how: https://bit.ly/3Snadro #InformationManagement #LifeSciences #Pharma

A deep dive into the complex playing field for #marketingandadvertising and partnering pursuits in today’s increasingly make-or-break landscape for #biopharma innovation #industrytrends #pharmaceuticalindustry #lifesciences

Our article featured in INTELLIGENT health.tech magazine discovers how Fractional CTOs can fill the gap of technical leadership in pharma companies. ➡️ The full article can be found here: https://lnkd.in/dRug5Dfw Most of the pharma companies do not possess Chief Information Technology Officers. Yet they should. Read the article and find out what are the most cost-effective options to get senior technical leadership at a fraction of the cost. Thank you to Intelligent Health.tech and Lynchpin Media for featuring the article and Ellen Flannery for managing the project. #pharma #pharmaceuticalindustry #pharmaceutical #cto #ctoinsights #fractionalcto #fractional #fractionalleadership #fractionalexecutive #chieftechnologyofficer #intelligent #health #tech #healthtech

Pharmaceutical companies require guidance in Information Technology, but employing a full-time Chief Technology Officer is often excessive. Due to limited IT operations and the high expense associated with the position, many pharmaceutical companies choose to go without a CTO - staying blind to the technological direction. Check out the article shared in the post below to discover why a Fractional Chief Technology Officer presents the most cost-effective solution for addressing pharmaceutical information technology needs. #pharma #pharmaceutical #pharmaceuticalindustry #cto #chieftechnologyofficer #fractional #fractionalcto #pharmacto